7.78
Chromadex Corp stock is traded at $7.78, with a volume of 81,073.
It is up +0.91% in the last 24 hours and up +32.71% over the past month.
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
See More
Previous Close:
$7.72
Open:
$7.76
24h Volume:
81,073
Relative Volume:
0.11
Market Cap:
$586.18M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-111.14
EPS:
-0.07
Net Cash Flow:
$6.97M
1W Performance:
+1.17%
1M Performance:
+32.71%
6M Performance:
+119.44%
1Y Performance:
+280.00%
Chromadex Corp Stock (CDXC) Company Profile
Name
Chromadex Corp
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare CDXC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CDXC
Chromadex Corp
|
7.701 | 586.18M | 83.57M | -4.94M | 6.97M | -0.07 |
![]()
KHC
Kraft Heinz Co
|
30.39 | 36.98B | 25.85B | 2.74B | 3.02B | 2.26 |
![]()
GIS
General Mills Inc
|
59.63 | 33.00B | 19.90B | 2.60B | 2.80B | 4.60 |
![]()
K
Kellanova
|
82.26 | 28.11B | 12.75B | 1.34B | 1.13B | 3.87 |
![]()
MKC
Mccormick Co Inc
|
80.42 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
![]()
HRL
Hormel Foods Corp
|
29.53 | 16.31B | 11.92B | 805.04M | 1.01B | 1.46 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
Mar-08-22 | Initiated | ROTH Capital | Buy |
Oct-16-19 | Initiated | Oppenheimer | Outperform |
Feb-14-19 | Initiated | B. Riley FBR | Buy |
Nov-27-17 | Resumed | H.C. Wainwright | Buy |
Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Chromadex Corp Stock (CDXC) Latest News
Q1 Earnings Forecast for ChromaDex Issued By HC Wainwright - Defense World
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace
ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India
Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan
ChromaDex to Present at the 37th Annual Roth Conference - Bluefield Daily Telegraph
Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan
ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World
ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia
Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Shares Bought by Rhumbline Advisers - Defense World
Truist Financial Corp Makes New $54,000 Investment in ChromaDex Co. (NASDAQ:CDXC) - Defense World
StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - Defense World
ChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says - Defense World
FY2025 EPS Estimates for ChromaDex Boosted by Roth Capital - Defense World
Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises - Investing.com Australia
ChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
ChromaDex stock soars to 52-week high, touches $7.98 By Investing.com - Investing.com Canada
ChromaDex Reports Record Revenues Amid Challenges - TipRanks
Tru Niagen’s ChromaDex reports profit, nearly $100 million in yearly sales - SupplySide Supplement Journal
ChromaDex stock soars to 52-week high, touches $7.98 - Investing.com India
ChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call Transcript - Insider Monkey
ChromaDex: Q4 Earnings Snapshot - Midland Daily News
ChromaDex Corp (CDXC) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Yahoo Finance
ChromaDex shares rise as Q4 results top estimates - Investing.com India
ChromaDex Reports Strong 2024 Financial Performance - TipRanks
Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa
Chromadex Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates - MSN
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results - BioSpace
Chromadex Corp earnings beat by $0.07, revenue topped estimates - Investing.com South Africa
CHROMADEX Earnings Results: $CDXC Reports Quarterly Earnings - Nasdaq
ChromaDex shares rise as Q4 results top estimates By Investing.com - Investing.com South Africa
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results -March 04, 2025 at 04:56 pm EST - Marketscreener.com
Chromadex Reports Strong Q4 2024 Financial Growth - TipRanks
ChromaDex: Q4 Earnings Snapshot -March 04, 2025 at 04:17 pm EST - Marketscreener.com
ChromaDex sees FY25 revenue growth roughly 18% - TipRanks
ChromaDex sees FY25 revenue up 18% - TipRanks
What To Expect From ChromaDex Corp (CDXC) Q4 2024 Earnings - GuruFocus.com
CHROMADEX Earnings Preview: Recent $CDXC Insider Trading, Hedge Fund Activity, and More - Nasdaq
ChromaDex (CDXC) Expected to Announce Earnings on Tuesday - Defense World
ChromaDex (NASDAQ:CDXC) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
Dartmouth Wants Fed. Circ. To Ax Fees After Vitamin IP Loss - Law360
Chromadex Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView
ChromaDex analysis of NR products yields ‘disappointing’ results - NutraIngredients-usa.com
Investor Network: ChromaDex Corporation to Host Earnings Call - ACCESS Newswire
ChromaDex Corporation to Host Earnings Call - ACCESS Newswire
Chromadex Corp Stock (CDXC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Chromadex Corp Stock (CDXC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):